Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Baxter
Medtronic
Harvard Business School
Moodys

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for COBALT LABORATORIES INC. v. FOOD AND DRUG ADMINISTRATION (D.C. 2008)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in COBALT LABORATORIES INC. v. FOOD AND DRUG ADMINISTRATION
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for COBALT LABORATORIES INC. v. FOOD AND DRUG ADMINISTRATION (D.C. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-05-08 1 Complaint only Orange Book-listed patent: U.S. Patent No. 4,904,769 (“the ‘769 patent”). As such, Cobalt is the…Book-listed patent for the NDA drug: (I) that there is no patent information; (II) that the listed patent has …after the expiration of the listed patent; or (IV) that the listed patent is invalid and/or will not be infringed…the first challenge to a brand company’s listed patent. Cobalt’s exclusivity remains intact and has not…, as amended by the Drug Price Competition and Patent Terrn Restoration Act of 1984, Pub. L. No. 98-417 External link to document
2008-05-08 3 Motion for Extension of Time re Transcript Nos. 5..64 446 lexpires lll'.’,J/’_’OlO). 4~783.337 respires 91_16/?.003). 4 165 989 expires ' …the OB_Rx list. Patent Data Appl Prod Patent Patent Drug Substance Drug Product Patent Use Delist . No…listed patents and to ‘design around’ patents to find altemative, non-infringing forms of patented drugs… to a listed patent must provide the NDA holder and the patent owner notice cf its patent cerdiication…There rs one patent listed for Acarbose Tablets, U. S. Patent No. 4, 904, 769 (the ‘769 patent), which expires External link to document
2008-05-09 9 Memorandum in Opposition mellitus. Bayer submitted U.S. Patent Number 4,904,769 (“the ‘769 patent”) to FDA for listing in the Orange… any patent that claims the drug, or a method of using the drug, and for which a claim of patent infringement… (I) that the required patent information relating to such patent has not been filed… (II) that such patent has expired; (III) that such patent will expire on a particular…wishes to challenge the validity of a patent, or to claim that the patent would not be infringed by the product External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Medtronic
Merck
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.